Jones Day Talks Health Care & Life Sciences: What Digital Health Innovators Should Know about the FDA Approval Process

Jones Day
Contact
Jones Day partner Ann Hollenbeck shares an informative conversation with associate Ian Pearson, who was a lead in the area of digital health at the U.S. Food and Drug Administration. They discuss how the FDA is addressing the challenges resulting from the rapidly growing and changing digital health marketplace. Mr. Pearson explains the Agency’s Digital Health Innovation Plan and why it’s important that companies participating in this sector engage with the FDA in the early stages of development. (Running time: 14:36)
Embed
Copy

Other MultiMedia by Jones Day

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Jones Day | Attorney Advertising

Written by:

Jones Day
Contact
more
less

PUBLISH YOUR CONTENT ON JD SUPRA NOW

  • Increased visibility
  • Actionable analytics
  • Ongoing guidance

Jones Day on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide